Lymphocyte populations and cell-mediated immunity in juvenile insulin-dependent diabetes mellitus. 1981

M Kadranka-Lovrencić, and S Rabatić, and A Sabioncello, and R Mazuran, and V Oberiter, and D Dekaris

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D012397 Rosette Formation The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immunocytoadherence,Formation, Rosette,Formations, Rosette,Immunocytoadherences,Rosette Formations
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

M Kadranka-Lovrencić, and S Rabatić, and A Sabioncello, and R Mazuran, and V Oberiter, and D Dekaris
May 1995, Diabetes research and clinical practice,
M Kadranka-Lovrencić, and S Rabatić, and A Sabioncello, and R Mazuran, and V Oberiter, and D Dekaris
January 1975, Diabetes,
M Kadranka-Lovrencić, and S Rabatić, and A Sabioncello, and R Mazuran, and V Oberiter, and D Dekaris
January 1984, Biomedica biochimica acta,
M Kadranka-Lovrencić, and S Rabatić, and A Sabioncello, and R Mazuran, and V Oberiter, and D Dekaris
January 1983, Czechoslovak medicine,
M Kadranka-Lovrencić, and S Rabatić, and A Sabioncello, and R Mazuran, and V Oberiter, and D Dekaris
October 1983, Minerva pediatrica,
M Kadranka-Lovrencić, and S Rabatić, and A Sabioncello, and R Mazuran, and V Oberiter, and D Dekaris
June 1983, Neurology,
M Kadranka-Lovrencić, and S Rabatić, and A Sabioncello, and R Mazuran, and V Oberiter, and D Dekaris
November 1977, Lancet (London, England),
M Kadranka-Lovrencić, and S Rabatić, and A Sabioncello, and R Mazuran, and V Oberiter, and D Dekaris
June 1974, Proceedings of the Royal Society of Medicine,
M Kadranka-Lovrencić, and S Rabatić, and A Sabioncello, and R Mazuran, and V Oberiter, and D Dekaris
August 1978, Infection and immunity,
M Kadranka-Lovrencić, and S Rabatić, and A Sabioncello, and R Mazuran, and V Oberiter, and D Dekaris
December 1974, Clinical and experimental immunology,
Copied contents to your clipboard!